Synthesis of IFN-β by Virus-Infected Chicken Embryo Cells Demonstrated with Specific Antisera and a New Bioassay by Schwarz, Heike et al.
JOURNAL OF INTERFERON & CYTOKINE RESEARCH 24:179–184 (2004)
© Mary Ann Liebert, Inc.
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ABSTRACT
Transcripts of interferon-a (IFN-a) and IFN-b genes are present in virus-infected chicken cells, but because
of a lack of appropriate assays and reagents, it was unclear if biologically active IFN-b is secreted. We have
established a nonviral bioassay for the sensitive detection of chicken IFN (ChIFN). This assay is based on a
quail cell line that carries a luciferase gene that is controlled by the IFN-responsive chicken Mx promoter.
Luciferase activity was strongly stimulated when the indicator cells were incubated with ChIFN-a, ChIFN-
b, or ChIFN-g but not with chicken interleukin-1b (ChIL-1b). Unlike the classic antiviral assay that prefer-
entially detects ChIFN-a, the Mx-luciferase assay detected ChIFN-a and ChIFN-b with similar sensitivity.
With the help of this novel assay and with rabbit antisera specific for either IFN-a or IFN-b, we analyzed
the composition of IFN in supernatants of virus-infected chicken embryo cells. Virtually all IFN produced in
response to Newcastle disease virus (NDV) was IFN-a. However, IFN produced in response to influenza A or
vaccinia virus (VV) was a mixture of usually more than 80% IFN-a and up to 20% IFN-b. Thus, IFN-a and
IFN-b both contribute to the cytokine activity in supernatants of virus-infected chicken cells. Furthermore,
the infecting virus appears to determine the IFN subtype composition.
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INTRODUCTION
THE FIRST CDNA FOR VIRUS-INDUCED chicken interferon(ChIFN) was cloned in 1994.(1) Subsequent work revealed
that the chicken uses at least 10 intronless genes to provide IFN-
a.(2) Low-stringency hybridization screening of a phage library
resulted in identification of a distantly related intronless ChIFN
gene,(2) now designated IFN-b.(3) The IFN-a and IFN-b genes
are clustered and map to the tip of the long arm of the chicken
Z chromosome.(4) Because polyclonal antisera raised against re-
combinant IFN-a failed to neutralize the antiviral activity of
IFN-b,(2) it was concluded that chickens, like mammals, pos-
sess serologically distinct type I IFNs. However, it remained
unclear if IFN-b contributes to the antiviral state in chickens
because an IFN-a-specific antiserum almost completely neu-
tralized the antiviral activity secreted by either chicken spleen
cells in response to concanavalin A (ConA)(5) or chicken em-
bryo cells in response to DNA transfection.(6) Furthermore,
birds injected with monoclonal antibody (mAb) 8A9, which
specifically neutralizes ChIFN-a, showed enhanced tumor in-
cidence in Rous sarcoma virus-infected chickens.(7) As work
with recombinant chicken cytokines indicated that the specific
antiviral activity of IFN-b was approximately 10-fold lower
than that of IFN-a,(2) it remained unclear whether the magni-
tude of ChIFN-b synthesis had been underestimated previously.
Recent research interest focuses on the question of why many
viruses manage to replicate surprisingly well in the face of a
strong innate immune response of the infected hosts.(8) Emerg-
ing evidence indicates that most successful viruses, including
such pathogens of poultry as Newcastle disease virus (NDV)
and influenza A virus, code for proteins that interfere with the
IFN system. For example, the NS1 protein of influenza A virus
limits IFN production in infected cells presumably by seques-
tering double-stranded RNA (dsRNA),(9) which would other-
wise trigger toll-like receptor-3 (TLR-3) activation and other
innate immune responses. The V protein of NDV has a differ-
ent mode of action against the host IFN response. It limits the
action of IFN by blocking IFN-dependent signaling path-
ways.(10–12) Pathogenesis studies of these viruses in avian hosts
are hampered by incomplete knowledge of the ChIFN system
and by a shortage of suitable reagents.
We have developed specific antisera to ChIFN-a and
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ChIFN-b and set up an alternative bioassay that detects IFN-b
with high sensitivity. Our experiments demonstrated that IFN-
a and IFN-b can both be produced during infection of chicken
embryo cells with viruses, such as influenza A virus.
MATERIALS AND METHODS
Recombinant chicken cytokines
Human 293T cells were transiently transfected with cDNA
expression constructs (pcDNA vector) (Invitrogen, San Diego,
CA) for ChIFN-a,(2) ChIFN-b,(2) ChIFN-g,(5,13) and N-termi-
nally truncated interleukin-1b (IL-1b) (ATG-80-11-12(14)). At
16–20 h after plasmid transfection, the medium was changed.
Media containing the various cytokines were harvested 48 h
later, and cell debris was removed by centrifugation. Short-term
storage of the samples was at 4°C, and long-term storage was
at 220°C.
Virus-induced natural ChIFN
Confluent monolayers of cells prepared from 10–day-old
chicken embryos were infected with various viruses at a mul-
tiplicity of infection (moi) of 5. Viruses used in this study 
were NDV strain H53,(15) influenza A virus PR8 lacking the
NS1 gene (FluA),(9) modified vaccinia virus (VV) Ankara
(MVA),(16) Rift valley fever virus strain M19,(17) and the
Freiburg variant of Thogotovirus lacking the ability to synthe-
size the ML protein.(18) At approximately 48 hours post infec-
tion, the culture media were harvested. The cell debris was re-
moved by centrifugation, and the supernatants were treated with
perchloric acid as described.(19) At the end of the acid treat-
ment procedure, the pH was brought back into the neutral range,
the insoluble precipitate was removed by centrifugation, and
the cleared supernatants were stored at 4°C. Before use, the su-
pernatants were incubated overnight at 4°C with the indicated
amounts of the various antisera.
IFN assays
Antiviral assay. Vesicular stomatitis virus (VSV) was used
to challenge cytokine-treated CEC-32 quail cells as de-
scribed.(16)
Nonviral assay. A plasmid in which luciferase gene expres-
sion is controlled by a short fragment (position 2216 to 145)
of the chicken Mx promoter(20) was transfected into CEC-32
cells, and stably transfected cells were selected. These cells
were seeded at approximately 2 3 105 cells per well into 24-
well dishes. They were treated for 6 h with the indicated dilu-
tions of the various cytokines. Subsequently, the culture
medium was removed, and the cells were lysed in 100 ml lysis
buffer (Promega, Madison, WI). Samples of the lysate were
used for measuring luciferase activity using a kit (Promega) as
recommended by the manufacturer.
Antisera
The rabbit antiserum against ChIFN-a has been described
previously.(2,5) The rabbit antiserum to ChIFN-b was produced
by repeated intramuscular (i.m.) injections of purified, bacteri-
ally produced ChIFN-b emulsified in Freund’s complete (first
immunization) or incomplete (subsequent immunizations) ad-
juvant. Both antisera were used individually at 0.5% or in com-
bination at 0.5% each. Preimmune sera used at the same con-
centrations served as negative controls.
RESULTS
An alternative bioassay for ChIFN
IFN activity is traditionally determined with antiviral assays
in which cytokine-treated cells are analyzed for acquired resis-
tance to infection by a challenge virus.(21) Alternative assays
rely on the fact that biologically active IFN triggers a signal-
ing cascade in susceptible cells that causes transcriptional acti-
vation of many genes, including Mx. We, therefore, established
a quail cell line that carries a luciferase reporter gene controlled
by the IFN-stimulated response element (ISRE) of the chicken
Mx promoter.(20) The quail cell line CEC-32 was used because
previous work demonstrated that it has favorable growth prop-
erties and that it responds to ChIFNs with high sensitivity.(2,5)
To determine if this indicator cell line would show the expected
IFN response, we exposed the cells for 6 h to various recom-
binant chicken cytokines. Exposure to IFN-a and IFN-b re-
sulted in approximately 30-fold increased levels of luciferase
activity compared with the untreated control (Fig. 1). IFN-g
was also active in this assay, although the luciferase levels were
enhanced only about 10-fold. In contrast, treatment of the in-
dicator cell line with a high dose of ChIL-1b did not cause sig-
nificantly enhanced luciferase levels (Fig. 1).
Supernatants of human 293T cells transiently transfected
with expression plasmids for chicken ChIFN-a or ChIFN-b re-
mained active until diluted at least 1,000,000-fold (Fig. 2, left),
indicating a very high sensitivity of the new bioassay. In re-
peated experiments, half-maximal luciferase values were ob-
tained with recombinant ChIFN-a (rChIFN-a) that was diluted
some 160,000-fold and rChIFN-b that was diluted some
SCHWARZ ET AL.180
0
500
1000
1500
2000
2500
R
el
at
iv
e 
lig
ht
 u
ni
ts
IFN-a IFN-b IFN-g IL-1b mock
FIG. 1. IFN response of indicator cells carrying an Mx pro-
moter-controlled luciferase reporter gene. The indicator cells
were incubated for 6 h with 1000-fold diluted supernatants 
of transfected human 293T cells expressing empty pcDNA1
(mock) or pcDNA1 vectors encoding either ChIFN-a, ChIFN-
b, ChIFN-g, or ChIL-1b.
60,000-fold. rIFN-g was far less active. Half-maximal lucifer-
ase values were measured with approximately 500-fold diluted
293T cell supernatant (data not shown). Classic antiviral as-
says (Fig. 2, right) demonstrated that the IFN-a preparation
used had a titer of 160,000 U/ml, whereas the titer of the IFN-
b preparation was about 12,000 U/ml. Thus, IFN-a was de-
tected with comparable sensitivity by both assays, whereas
IFN-b was detected about 5-fold better by the Mx-luciferase
assay.
Antisera specifically neutralizing either ChIFN-a
or ChIFN-b
We previously described a rabbit antiserum that efficiently
neutralized ChIFN-a but not ChIFN-b.(2) By repeated immu-
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FIG. 2. The Mx-luciferase assay detects IFN-b with higher sensitivity than the classic antiviral assay. End point titrations of
rChIFN-a and rChIFN-b from transfected 293T cells were performed in the two alternative assays.
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FIG. 3. Rabbit antisera exhibit a high degree of selectivity for rIFN-a and rIFN-b in the Mx-luciferase assay (A) and in the
classic antiviral assay (B). Antisera were used at 0.5% each. Control serum was used at 0.5%.
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nization of a rabbit with purified rChIFN-b, we also gener-
ated an antiserum with high specificity for IFN-b. When used
at a final concentration of 0.5%, the IFN-a antiserum reduced
the activity of rChIFN-a from transfected human 293T cells
by about 60-fold. The IFN-b antiserum was similarly effec-
tive against rChIFN-b (Fig. 3). Importantly, the two antisera
showed no measurable cross-reactivity; that is, each antiserum
exhibited a very high degree of specificity for the corre-
sponding IFN subtype (Fig. 3). Virtually identical datasets
were obtained with the Mx-luciferase assay (Fig. 3A) and the
antiviral assay (Fig. 3B).
Natural ChIFN-b in supernatants of virus-infected
embryo cells
Virus-infected chicken embryo cells are a good source of
natural type I IFN.(19) We, therefore, infected these cells with
a panel of viruses and assayed the supernatants for IFN activ-
ity at 48–72 h postinfection. In order to destroy the inducing
virus and to eliminate other activities that might interfere in the
IFN assay, the supernatants were subjected to extensive per-
chloric acid treatment as described.(19) High IFN activity was
repeatedly measured in supernatants of cells infected with ei-
ther NDV, FluA, MVA. In a typical experiment, such super-
natants strongly activated the Mx-luciferase construct in our in-
dicator cells if diluted less than approximately 1000-fold (Fig.
4). In the presence of a 1:1 mixture of IFN-a-specific and IFN-
b-specific antisera, the IFN activity in the various supernatants
was reduced some 60-fold (Fig. 4), demonstrating that natural
virus-induced ChIFN consists mainly of these two IFN sub-
types. In the exclusive presence of antiserum to IFN-a, the su-
pernatant from NDV-induced cells lost all its activity (Fig. 4),
indicating that almost no IFN-b was present. In contrast, anti-
serum to IFN-a alone was rather ineffective on supernatants
from cells infected with either influenza A virus or MVA. In-
clusion of antiserum to IFN-a alone reduced the activity of these
supernatants only about 4–8-fold compared with about 60-fold
if both antisera were present (Fig. 4). In the exclusive presence
of antiserum to IFN-b, no significant changes in the IFN ac-
tivity were recorded. These observations suggested that IFN-a
was responsible for about 80% of the IFN activity in the su-
pernatants of cells infected with influenza A virus or MVA.
Furthermore, these data unambiguously demonstrated that a
small fraction of the IFN activity (20% or less) was due to the
presence of IFN-b.
Our results also illustrated clearly that detection of minor
IFN subtypes in mixed IFN preparations can be very demand-
ing. The difficulty stems from the fact that the bioassays can-
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FIG. 4. Natural IFN in supernatants of virus-infected chicken embryo cells is a mixture of IFN-a and IFN-b. Confluent cell
monolayers were infected with either FluA, NDV, MVA at an moi of 5. Forty-eight hours later, the supernatants were harvested
and treated with acid to destroy virus. IFN composition and titers were determined with the Mx-luciferase assay using the spe-
cific antisera as in Figure 3.
not distinguish between preparations with titer differences of
less than 2-fold. Only after the dominant IFN species is neu-
tralized does the activity of the other subtypes become readily
detectable. We noted that overall synthesis of IFN and relative
amount of IFN-b produced in response to infection with in-
fluenza A virus and MVA varied considerably between exper-
iments (data not shown). The reason for this variability is un-
known at present. It may be related to the fact that primary
chick embryo cells require proper aging in vitro before they re-
spond to external stimuli with vigorous IFN synthesis.(19,22)
DISCUSSION
Although chickens possess genes for IFN-a and IFN-b, sev-
eral previous observations suggested that IFN-b may not con-
tribute significantly to the antiviral defense of chickens. Using
conventional IFN titration assays that measure the antiviral 
activity of the cytokine against VSV, the specific activity of
rChIFN-b was found to be about 10-fold lower than that of
ChIFN-a.(2) Selective in vivo neutralization of IFN-a with an
mAb resulted in enhanced tumor incidence in Rous sarcoma
virus-infected chickens.(7) Finally, the application of antisera to
IFN-a alone abrogated plasmid DNA transfection-induced anti-
viral state of chicken embryo cells toward an IFN-sensitive
NDV strain.(6) The experiments described in this report were
performed to determine if IFN-b is indeed produced under
physiologic conditions. By using a nonviral IFN assay, we
found that IFN-a and IFN-b exhibit comparable specific ac-
tivities, arguing against the possibility that the previously ob-
served reduced antiviral activity of rChIFN-b resulted from
technical problems associated with the production and purifi-
cation of this cytokine. Direct evidence that biologically active
IFN-b is secreted by virus-infected chicken cells came from ex-
periments in which antisera with high specificity for either IFN-
a or IFN-b were used. These studies revealed that IFN-a is the
dominant virus-induced IFN subtype of chicken embryo cells.
They further showed that infection of these cells by some but
clearly not all viruses also leads to secretion of detectable lev-
els of IFN-b.
The new Mx-luciferase bioassay we used for measuring IFN
activity has several advantages over the conventional antiviral
assay. Unlike the antiviral assay, the Mx-luciferase assay de-
tects IFN-a and IFN-b with high sensitivity, it is very fast and
can be completed in about 7 h, and it works without infectious
agents and can thus be performed in laboratories that lack a per-
mit for work with potentially dangerous viruses. Like the con-
ventional antiviral assay, the Mx-luciferase assay is not specific
for type I IFN but responds to IFN-g. This latter property was
unexpected because the mammalian Mx genes are preferentially
induced by IFN-a and IFN-b. It should be noted that our indi-
cator cells carry a reporter gene that is controlled by an artifi-
cially truncated Mx promoter consisting of less than 250 nt of
regulatory sequence that contain positive acting elements but
might lack some control elements that determine type I IFN
specificity. It is also possible that the Mx genes of birds show
an intrinsically less restricted response to the various IFN sub-
types. The literature contains insufficient data on the regulation
of the endogenous Mx gene of the chicken to distinguish be-
tween these possibilities.
The antisera we generated by repeated immunization of rab-
bits with bacterially produced either IFN-a or IFN-b showed a
very high degree of specificity for the corresponding IFN sub-
type. Thus, as in mammals, IFN-a and IFN-b of the chicken
are serologically distinct cytokines. This property confirms the
validity of the recently introduced nomenclature of ChIFNs in
which the nomenclature previously used for mammalian IFNs
was applied.(3) The high specificity of the antisera allowed us
for the first time to perform a complete analysis of the IFN
composition in the medium of virus-infected chicken cells. Our
observation that IFN-awas predominantly present in these sam-
ples fits nicely with earlier reports that stressed the importance
of IFN-a in the antiviral defense of the chicken. It is important
to note, however, that the VV and the influenza A virus used
in this study also induced good quantities of biologically active
IFN-b, whereas NDV (Fig. 4), Thogoto virus, and Rift valley
fever virus (unpublished observations) did not. This contrasts
with the situation in mammals in which IFN-b is the dominant
type I IFN species produced by virus-infected cells. These sub-
tle differences in gene regulation and the reduced specific anti-
viral activity toward VSV of chicken IFN-b may be taken as
preliminary evidence that IFN-a primarily serves the antiviral
defense in chickens. A picture thus emerges in which ChIFN-
b appears to primarily serve a different as yet undefined phys-
iologic role, such as, for example, promoting the maturation of
dendritic cells in response to viral infection.(23)
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